Phase
Condition
Bladder Cancer
Urothelial Cancer
Urothelial Carcinoma
Treatment
Sugar pill
Genistein
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female gender
18 years or older
Diagnosis of superficial bladder cancer
Scheduled for induction BCG intravesical therapy
Willing and able to give blood sample
Willing and able to fill out a pill diary to ensure compliance
Willing and able to sign informed consent
Birth control is not required for this study!
Exclusion
Exclusion Criteria:
Patients who are pregnant
Diagnosis of muscle-invasive bladder cancer
Unwillingness to follow study protocol and compliance procedures
HIV positive or immunocompromised
Receiving concurrent immunotherapy or chemotherapy
Presence of concurrent second cancer (active, not history)
Study Design
Study Description
Connect with a study center
Emory University Department of Urology
1365 Clifton Road NE, Georgia 30322
United StatesSite Not Available
Emory Saint Joseph's Hospital
Atlanta, Georgia 30342
United StatesSite Not Available
Emory University Department of Urology
Atlanta, Georgia 30322
United StatesSite Not Available
Emory University Hospital Midtown
Atlanta, Georgia 30308
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.